Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Literature
1.
Masamune A, Nabeshima T, Kikuta K, et al. Prospective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria. J Gastroenterol. 2019.
2.
Masamune A, Kume K, Shimosegawa T. Sex and age differences in alcoholic pancreatitis in Japan: a multicenter nationwide survey. Pancreas. 2013;42:578–83.CrossRef
3.
Hao L, Bi YW, Zhang D, et al. Risk factors and nomogram for common bile duct stricture in chronic pancreatitis: a cohort of 2153 patients. J Clin Gastroenterol. 2019;53:e91–e100.CrossRef
4.
Hirth M, Weiss C, Hardt P, et al. Analysis of the course of chronic pancreatitis: pancreatic burnout rates are only increased in a subgroup of patients with alcoholic chronic pancreatitis. Pancreas. 2019;48:726–33.CrossRef
Metadata
Title
Study of early chronic pancreatitis needs to be improved
Authors
Yu Liu
Dan Wang
Zhao-Shen Li
Liang-Hao Hu
Publication date
01-01-2020
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 1/2020
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-019-01632-3

Other articles of this Issue 1/2020

Journal of Gastroenterology 1/2020 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset

Original Article—Liver, Pancreas, and Biliary Tract

Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society

Letter to the Editor

Evolution of hepatocellular carcinoma: non-B, non-C and beyond

Original Article—Liver, Pancreas, and Biliary Tract

Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes

Original Article—Alimentary Tract

High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma

Correction

Correction to: High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits